The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer
Wei Yen Chan(Melanoma Institute Australia), Stephanie Hui Lim(Liverpool Hospital), Cheok Soon Lee(Liverpool Hospital), Weng Ng(Sir Run Run Shaw Hospital), Tara L. Roberts(Camden and Campbelltown Hospitals), Therese M. Becker(Liverpool Hospital), Kate Wilkinson(Liverpool Hospital), Chandika Epitakaduwa(Liverpool Hospital), Joseph Descallar(UNSW Sydney), Wei Chua(Liverpool Hospital), Hiren Mandaliya(Camden and Campbelltown Hospitals)
Cited by 1
Related Papers
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|614
Cutting Edge: Species-Specific TLR9-Mediated Recognition of CpG and Non-CpG Phosphorothioate-Modified Oligonucleotides
|The Journal of Immunology|2005|133
Changes in plasma biochemistry in horses competing in a 160 km endurance ride
|Australian Veterinary Journal|1983|60
A systematic review of surgical ablation versus catheter ablation for atrial fibrillation.
|PubMed|2013|54
Myoepithelial cell‐specific expression of stefin A as a suppressor of early breast cancer invasion
|The Journal of Pathology|2017|52